Vetter’s European clinical site receives permanent Manufacturer’s Authorization
11/09/2023
Ongoing investments in the supply chain for complex injectable medications
10/17/2023
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services
08/29/2023
We just published our annual sustainability report.
06/14/2023
Vetter honored as an exceptionally managed company.
05/30/2023
Vetter further expands offerings for clinical development and manufacturing.
05/09/2023
03/31/2023
Vetter honored as winner in all six core award categories.
03/27/2023
Vetter strengthens worldwide commitment to sustainable business practices
03/06/2023
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
02/01/2023
Vetter significantly increases its sustainability rating.
01/18/2023
Vetter’s SVP Key Account Management, Supply Chain Management (SCM), & Marketing reflects on a volatile year and looks ahead to 2023.
12/14/2022
